Similarly, there is no evidence that RBP3 (“Retinol binding protein 3, interstitial”) is involved in retinoblastoma, nor that MLL3 (“myeloid/lymphoid or mixed-lineage leukemia 3”) is involved in leukemia. Here, KMT2C is linked to leukemia.